Detailed information for compound 54748

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 521.353 | Formula: C22H22Cl2N6O5
  • H donors: 3 H acceptors: 7 LogP: 4.4 Rotable bonds: 12
    Rule of 5 violations (Lipinski): 2
  • SMILES: CCCOc1nc(OC)nc(n1)N[C@H](C(=O)O)Cc1ccc(cc1)NC(=O)c1c(Cl)cncc1Cl
  • InChi: 1S/C22H22Cl2N6O5/c1-3-8-35-22-29-20(28-21(30-22)34-2)27-16(19(32)33)9-12-4-6-13(7-5-12)26-18(31)17-14(23)10-25-11-15(17)24/h4-7,10-11,16H,3,8-9H2,1-2H3,(H,26,31)(H,32,33)(H,27,28,29,30)/t16-/m0/s1
  • InChiKey: ZKWILEMTQDEYRU-INIZCTEOSA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor) References
Homo sapiens integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Schistosoma japonicum Integrin beta-3 precursor, putative Get druggable targets OG5_127959 All targets in OG5_127959
Schistosoma mansoni integrin beta subunit Get druggable targets OG5_127959 All targets in OG5_127959
Brugia malayi Integrin beta pat-3 precursor Get druggable targets OG5_127959 All targets in OG5_127959
Schistosoma japonicum Integrin beta-PS precursor, putative Get druggable targets OG5_127959 All targets in OG5_127959
Echinococcus granulosus integrin beta 2 Get druggable targets OG5_127959 All targets in OG5_127959
Echinococcus multilocularis integrin beta 2 Get druggable targets OG5_127959 All targets in OG5_127959
Loa Loa (eye worm) integrin beta-2 Get druggable targets OG5_127959 All targets in OG5_127959
Schistosoma japonicum ko:K06464 integrin beta 2, putative Get druggable targets OG5_127959 All targets in OG5_127959
Schistosoma mansoni integrin alpha-4 Get druggable targets OG5_133980 All targets in OG5_133980

By sequence similarity to non orthologous known druggable targets
Species Potential target Known druggable target Length Alignment span Identity
Echinococcus multilocularis integrin alpha 3 integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor) 1032 aa 873 aa 22.0 %

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Echinococcus multilocularis nicotinic acetylcholine receptor a11 subunit 0.0106 0.0415 0.0254
Loa Loa (eye worm) hypothetical protein 0.0057 0.002 0.0077
Echinococcus granulosus transient receptor potential cation channel 0.037 0.2579 0.2454
Echinococcus multilocularis thymidine phosphorylase 0.1276 1 1
Echinococcus multilocularis acetylcholinesterase 0.0219 0.1345 0.12
Loa Loa (eye worm) hypothetical protein 0.0106 0.0415 0.1566
Echinococcus granulosus geminin 0.0388 0.2727 0.2605
Echinococcus granulosus tm gpcr rhodopsin 0.1157 0.9028 0.9012
Brugia malayi RNA recognition motif domain containing protein 0.0075 0.0165 0.0624
Echinococcus multilocularis integrin alpha ps 0.011 0.0454 0.0293
Schistosoma mansoni tar DNA-binding protein 0.0075 0.0165 0.0427
Schistosoma mansoni integrin alpha-ps 0.011 0.0454 0.1276
Loa Loa (eye worm) hypothetical protein 0.0057 0.002 0.0077
Mycobacterium ulcerans thymidine phosphorylase 0.1276 1 1
Brugia malayi hypothetical protein 0.0057 0.002 0.0077
Schistosoma mansoni tar DNA-binding protein 0.0075 0.0165 0.0427
Brugia malayi MH2 domain containing protein 0.0142 0.071 0.2681
Echinococcus multilocularis ankyrin repeat protein 0.0355 0.246 0.2333
Brugia malayi TAR-binding protein 0.0075 0.0165 0.0624
Echinococcus multilocularis acetylcholinesterase 0.0219 0.1345 0.12
Schistosoma mansoni tar DNA-binding protein 0.0075 0.0165 0.0427
Loa Loa (eye worm) TAR-binding protein 0.0075 0.0165 0.0624
Echinococcus multilocularis tm gpcr rhodopsin gpcr rhodopsin superfamily 0.1157 0.9028 0.9012
Mycobacterium leprae Probable anthranilate phosphoribosyltransferase TrpD 0.036 0.2499 0.5
Brugia malayi Carboxylesterase family protein 0.0219 0.1345 0.5081
Schistosoma mansoni integrin alpha-4 0.0472 0.3417 1
Loa Loa (eye worm) hypothetical protein 0.0219 0.1345 0.5081
Echinococcus multilocularis transient receptor potential cation channel 0.037 0.2579 0.2454
Brugia malayi RNA binding protein 0.0075 0.0165 0.0624
Echinococcus granulosus acetylcholinesterase 0.0219 0.1345 0.12
Schistosoma mansoni hypothetical protein 0.0388 0.2727 0.7971
Schistosoma mansoni integrin alpha 0.011 0.0454 0.1276
Loa Loa (eye worm) hypothetical protein 0.0057 0.002 0.0077
Brugia malayi Integrin alpha pat-2 precursor 0.011 0.0454 0.1714
Schistosoma mansoni integrin beta subunit 0.0223 0.1374 0.3986
Echinococcus granulosus integrin alpha ps 0.011 0.0454 0.0293
Loa Loa (eye worm) transcription factor SMAD2 0.0142 0.071 0.2681
Echinococcus multilocularis integrin alpha ps 0.011 0.0454 0.0293
Loa Loa (eye worm) nicotinic acetylcholine receptor alpha subunit 0.0106 0.0415 0.1566
Echinococcus granulosus acetylcholinesterase 0.0219 0.1345 0.12
Schistosoma mansoni hypothetical protein 0.0388 0.2727 0.7971
Loa Loa (eye worm) RNA binding protein 0.0075 0.0165 0.0624
Schistosoma mansoni family S9 non-peptidase homologue (S09 family) 0.0219 0.1345 0.3901
Echinococcus granulosus integrin beta 2 0.028 0.1845 0.1708
Brugia malayi Integrin beta pat-3 precursor 0.0378 0.2648 1
Loa Loa (eye worm) RNA recognition domain-containing protein domain-containing protein 0.0075 0.0165 0.0624
Loa Loa (eye worm) integrin beta-2 0.0378 0.2648 1
Echinococcus granulosus nicotinic acetylcholine receptor alpha subunit 0.0106 0.0415 0.0254
Echinococcus multilocularis carboxylesterase 5A 0.0219 0.1345 0.12
Echinococcus granulosus ankyrin repeat protein 0.0355 0.246 0.2333
Loa Loa (eye worm) acetylcholinesterase 1 0.0219 0.1345 0.5081
Echinococcus multilocularis nicotinic acetylcholine receptor alpha subunit 0.0106 0.0415 0.0254
Echinococcus granulosus carboxylesterase 5A 0.0219 0.1345 0.12
Brugia malayi Kelch motif family protein 0.0057 0.002 0.0077
Loa Loa (eye worm) carboxylesterase 0.0219 0.1345 0.5081
Loa Loa (eye worm) hypothetical protein 0.0219 0.1345 0.5081
Loa Loa (eye worm) MH2 domain-containing protein 0.0142 0.071 0.2681
Echinococcus multilocularis integrin beta 2 0.028 0.1845 0.1708
Onchocerca volvulus Putative nachr subunit 0.0106 0.0415 0.5
Brugia malayi nicotinic acetylcholine receptor alpha subunit, putative 0.0106 0.0415 0.1566
Schistosoma mansoni tar DNA-binding protein 0.0075 0.0165 0.0427
Echinococcus granulosus nicotinic acetylcholine receptor subunit alpha 8 0.0106 0.0415 0.0254
Echinococcus granulosus nicotinic acetylcholine receptor a11 subunit 0.0106 0.0415 0.0254
Loa Loa (eye worm) kelch domain-containing protein family protein 0.0057 0.002 0.0077
Mycobacterium tuberculosis Probable thymidine phosphorylase DeoA (tdrpase) (pyrimidine phosphorylase) 0.1276 1 1
Brugia malayi Carboxylesterase family protein 0.0219 0.1345 0.5081
Schistosoma mansoni transient receptor potential cation channel subfamily A member 0.0355 0.246 0.7183
Schistosoma mansoni tar DNA-binding protein 0.0075 0.0165 0.0427
Loa Loa (eye worm) integrin alpha pat-2 0.011 0.0454 0.1714
Echinococcus multilocularis nicotinic acetylcholine receptor subunit alpha 8 0.0106 0.0415 0.0254
Echinococcus multilocularis geminin 0.0388 0.2727 0.2605

Activities

Activity type Activity value Assay description Source Reference
IC50 (binding) = 45 nM Inhibition of VLA-4 from HL60 lysate in a protein-based ligand binding assay. ChEMBL. 12039569
IC50 (binding) = 45 nM Inhibition of VLA-4 from HL60 lysate in a protein-based ligand binding assay. ChEMBL. 12039569
IC50 (binding) = 300 nM Inhibition of VLA-4 expressed in Jurkat cell line, in a cell-based adhesion assay. ChEMBL. 12039569
IC50 (binding) = 300 nM Inhibition of VLA-4 expressed in Jurkat cell line, in a cell-based adhesion assay. ChEMBL. 12039569
k (ADMET) = 2.3 hr-1 Compound was evaluated for rate of clearance by using IPRL (Isolated Perfused Rat Liver) ChEMBL. 12039569

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.